Is Insight Molecular Diagnostics Inc. overvalued?

Insight Molecular Diagnostics Inc. (IMDX) — key valuation metrics and fundamentals.

No verdict

Price

$4.32

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$139.5M

Dividend yield

0.0%

Return on equity

271.8%

Sector

Healthcare

Fair value compares IMDX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks